Chengdu Kanghong Pharmaceutical Group's low P/E is maintaine...
Chengdu Kanghong Pharmaceutical Group's low P/E is maintained as investors find its earnings growth forecasts lower than market expectations. Lack of significant growth potential might continue to suppress share price.
There's No Escaping Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Muted Earnings
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment